{"protocolSection": {"identificationModule": {"nctId": "NCT00262119", "orgStudyIdInfo": {"id": "MNV-20-171005"}, "organization": {"fullName": "Medtronic Bakken Research Center", "class": "INDUSTRY"}, "briefTitle": "MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure", "officialTitle": "MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure"}, "statusModule": {"statusVerifiedDate": "2016-03", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2006-02"}, "primaryCompletionDateStruct": {"date": "2012-04", "type": "ACTUAL"}, "completionDateStruct": {"date": "2013-04", "type": "ACTUAL"}, "studyFirstSubmitDate": "2005-12-04", "studyFirstSubmitQcDate": "2005-12-04", "studyFirstPostDateStruct": {"date": "2005-12-06", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-05-09", "resultsFirstSubmitQcDate": "2014-05-09", "resultsFirstPostDateStruct": {"date": "2014-06-11", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2016-03-23", "lastUpdatePostDateStruct": {"date": "2016-04-21", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Medtronic Bakken Research Center", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "The aim of this study is to test the impact of the managed ventricular pacing (MVP) mode and atrial preventive and antitachycardia pacing therapies on the reduction of a composite clinical outcome composed of any death, permanent atrial fibrillation, and cardiovascular hospitalizations.", "detailedDescription": "Kristensen et al. reported that AAIR pacing reduces atrial fibrillation (AF) development compared to DDDR pacing in sinus node disfunction patients.\n\nSeveral authors have shown that, in patients with intact AV conduction, unnecessary chronic RV pacing can cause detrimental effects such as AF, left ventricular (LV) dysfunction and congestive heart failure. These findings arose the hypothesis that the non-physiologic nature of ventricular pacing may result in electrophysiological and LV remodeling changes that have potentially deleterious long-term effects.\n\nThe MVP mode, present in the Medtronic pacemaker EnRhythm, provides atrial based pacing with ventricular backup. It operates in true AAI(R) mode, it provides ventricular backup in case of a single conduction loss and converts to DDD(R) mode in case of persistent loss of AV conduction.\n\nAim of this study is to test the impact of the MVP pacing mode and atrial preventive and antitachycardia pacing therapies on the reduction of a composite clinical outcome composed by any death, permanent AF, cardiovascular hospitalizations."}, "conditionsModule": {"conditions": ["Atrial Fibrillation", "Heart Failure, Congestive"], "keywords": ["Physiological pacing", "Antitachycardia pacing therapies"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "PREVENTION", "maskingInfo": {"masking": "SINGLE", "whoMasked": ["PARTICIPANT"]}}, "enrollmentInfo": {"count": 1300, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Control Group", "type": "ACTIVE_COMPARATOR", "description": "PM programming according to actual clinical practice", "interventionNames": ["Device: Pacemaker Medtronic EnRhythm"]}, {"label": "MVP Only", "type": "ACTIVE_COMPARATOR", "description": "PM programming according to actual clinical practice + MVP algorithm ON", "interventionNames": ["Device: Pacemaker Medtronic EnRhythm"]}, {"label": "DDDRP", "type": "ACTIVE_COMPARATOR", "description": "PM programming according to actual clinical practice + MVP algorithm ON + Atrial fibrillation therapies ON", "interventionNames": ["Device: Pacemaker Medtronic EnRhythm"]}], "interventions": [{"type": "DEVICE", "name": "Pacemaker Medtronic EnRhythm", "description": "Pacemaker specific programming", "armGroupLabels": ["Control Group", "DDDRP", "MVP Only"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Composite Endpoint Composed by Death for Any Cause, Cardiovascular Hospitalization or Permanent AF at 2 Years", "description": "The outcome measurement is the 2 years incidence, calculated by Kaplan Meier survival analysis, of the composite endpoint composed by death for any cause, cardiovascular hospitalization or permanent AF.", "timeFrame": "2 years"}], "secondaryOutcomes": [{"measure": "Death for All Causes at 2 Years", "description": "Incidence, estimated via Kaplan Meier survival analysis, of death for any cause at 2 years", "timeFrame": "2 years"}, {"measure": "Incidence of Permanent Atrial Fibrillation at 2 Years", "description": "Incidence, estimated via Kaplan Meier survival analysis, of permanent atrial fibrillation at 2 years", "timeFrame": "2 years"}, {"measure": "Incidence of Cardiovascular Hospitalizations at 2 Years", "description": "Incidence, estimated via Kaplan Meier survival analysis, of cardiovascular hospitalizations at 2 years", "timeFrame": "2 years"}, {"measure": "Burden of Composite Clinical Endpoint", "timeFrame": "2 years"}, {"measure": "Subjects' Symptoms", "timeFrame": "2 years"}, {"measure": "Heart Failure Medications", "timeFrame": "2 years"}, {"measure": "Cumulative Percentage of Ventricular Pacing", "timeFrame": "2 years"}, {"measure": "Cardiovascular Death", "timeFrame": "2 years"}, {"measure": "Any Hospitalization", "timeFrame": "2 years"}, {"measure": "Atrial Fibrillation Burden", "timeFrame": "2 years"}, {"measure": "Persistent Atrial Fibrillation (AF)", "timeFrame": "2 years"}, {"measure": "Adverse Events", "timeFrame": "2 years"}, {"measure": "Development of Atrioventricular (AV) Block and Pacemaker Dependency", "timeFrame": "2 years"}, {"measure": "Predictors of Stroke, Transient Ischemic Attack (TIA) and Arterial Embolism", "timeFrame": "2 years"}, {"measure": "Echocardiogram Data About Left Ventricular Fractional Shortening and Ejection Fraction and Left Atrium Dilatation", "timeFrame": "2 years"}, {"measure": "Clinical Outcome in All the Patients With MVP ON Between Patients With Optimized AV-delay and Patients Without Optimized AV-delay", "timeFrame": "2 years"}, {"measure": "Time to Development of the Composite Endpoint Between All Randomized Subjects in the Three Arms in Subgroups of Patients", "timeFrame": "2 years"}, {"measure": "Frequency, Type, and Associated Cost of Health Care Utilization and Utility", "timeFrame": "2 years"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Class I/Class II indications for dual chamber pacing\n* Previous implant of an EnRhythm dual chamber implantable pulse generator (IPG) since maximum 2 weeks\n* History of atrial arrhythmias (at least one electrocardiogram \\[ECG\\] or Holter documented episodes in the last 12 months)\n\nExclusion Criteria:\n\n* Less than 18 years of age\n* Pregnancy\n* Unwilling or unable to give informed consent or to commit to follow-up schedule\n* Medical conditions that preclude protocol required testing or limit study participation\n* Enrolled or intend to participate in another clinical trial during the course of this study\n* A life expectancy of less than 2 years\n* Patient is a candidate for an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) device implant\n* Anticipated major cardiac surgery within the course of this study\n* Permanent III degree AV-block or history of AV node ablation\n* History of permanent AF (as defined below)\n* AF ablation (left pulmonary veins) or other cardiac surgery \\< 3 months\n* Prior implant of defibrillator device or pacemaker (apart from EnRhythm IPG implanted within two weeks)\n* Uncontrolled hyperthyroidism", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Luigi Padeletti, Prof.", "affiliation": "Ospedale Careggi - Firenze", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Giuseppe Boriani, Dr.", "affiliation": "Ospedale Sant'Orsola - Bologna", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Luis Mont, Dr.", "affiliation": "Hospital Clinic of Barcelona", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Reinhard C Funck, Dr.", "affiliation": "Philipps University Hospital - Marburg", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Carsten W Israel, Dr.", "affiliation": "J. W. Goethe University Hospital - Frankfurt", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Helmut P\u00fcrerfellner, Dr.", "affiliation": "Elisabethinen Hospital", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Antonis S Manolis, Prof.", "affiliation": "Evagelismos Hospital - Athens", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Andr\u00e9 Pisapia, Dr", "affiliation": "H\u00f4pital Saint-Joseph - Marseille", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Raymond Tukkie, Dr", "affiliation": "Kennemer Gasthuis", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Medtronic Italia S.p.A.", "city": "Rome", "zip": "00193", "country": "Italy", "geoPoint": {"lat": 41.89193, "lon": 12.51133}}]}, "referencesModule": {"references": [{"pmid": "10805823", "type": "BACKGROUND", "citation": "Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami MH, Talajic M, Tang AS, Klein GJ, Lau C, Newman DM. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med. 2000 May 11;342(19):1385-91. doi: 10.1056/NEJM200005113421902."}, {"pmid": "12063369", "type": "BACKGROUND", "citation": "Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G, Schron E, Orav EJ, Hellkamp AS, Greer S, McAnulty J, Ellenbogen K, Ehlert F, Freedman RA, Estes NA 3rd, Greenspon A, Goldman L; Mode Selection Trial in Sinus-Node Dysfunction. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002 Jun 13;346(24):1854-62. doi: 10.1056/NEJMoa013040."}, {"pmid": "9519322", "type": "BACKGROUND", "citation": "Mattioli AV, Vivoli D, Mattioli G. Influence of pacing modalities on the incidence of atrial fibrillation in patients without prior atrial fibrillation. A prospective study. Eur Heart J. 1998 Feb;19(2):282-6. doi: 10.1053/euhj.1997.0616."}, {"pmid": "9652562", "type": "BACKGROUND", "citation": "Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997 Oct 25;350(9086):1210-6. doi: 10.1016/S0140-6736(97)03425-9."}, {"pmid": "15145874", "type": "BACKGROUND", "citation": "Kristensen L, Nielsen JC, Mortensen PT, Pedersen OL, Pedersen AK, Andersen HR. Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome. Heart. 2004 Jun;90(6):661-6. doi: 10.1136/hrt.2003.016063."}, {"pmid": "9529267", "type": "BACKGROUND", "citation": "Nielsen JC, Andersen HR, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK. Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing. Circulation. 1998 Mar 17;97(10):987-95. doi: 10.1161/01.cir.97.10.987."}, {"pmid": "12932590", "type": "BACKGROUND", "citation": "Nielsen JC, Kristensen L, Andersen HR, Mortensen PT, Pedersen OL, Pedersen AK. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol. 2003 Aug 20;42(4):614-23. doi: 10.1016/s0735-1097(03)00757-5."}, {"pmid": "24771721", "type": "DERIVED", "citation": "Boriani G, Tukkie R, Manolis AS, Mont L, Purerfellner H, Santini M, Inama G, Serra P, de Sousa J, Botto GL, Mangoni L, Grammatico A, Padeletti L; MINERVA Investigators. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Eur Heart J. 2014 Sep 14;35(35):2352-62. doi: 10.1093/eurheartj/ehu165. Epub 2014 Apr 25."}, {"pmid": "18760124", "type": "DERIVED", "citation": "Funck RC, Boriani G, Manolis AS, Puererfellner H, Mont L, Tukkie R, Pisapia A, Israel CW, Grovale N, Grammatico A, Padeletti L; MINERVA Study Group. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. Am Heart J. 2008 Sep;156(3):445-51. doi: 10.1016/j.ahj.2008.05.004."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "A total of 1300 patients were enrolled in the study. Enrollment was followed by a 1-month run-in period. Patients with ventricular pacing \u2265 95% on device check in the run-in period were excluded from the study. At the end of the run-in period, randomization was performed. In all, 1166 patients were randomized and followed up.", "recruitmentDetails": "The recruitment period was between February 2006 and April 2010. Patients were enrolled in cardiology departments.", "groups": [{"id": "FG000", "title": "Control Group", "description": "PM programming according to actual clinical practice\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "FG001", "title": "MVP Only", "description": "PM programming according to actual clinical practice + MVP algorithm ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "FG002", "title": "DDDRP", "description": "PM programming according to actual clinical practice + MVP algorithm ON + Atrial fibrillation therapies ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "385"}, {"groupId": "FG001", "numSubjects": "398"}, {"groupId": "FG002", "numSubjects": "383"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "327"}, {"groupId": "FG001", "numSubjects": "328"}, {"groupId": "FG002", "numSubjects": "325"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "58"}, {"groupId": "FG001", "numSubjects": "70"}, {"groupId": "FG002", "numSubjects": "58"}]}], "dropWithdraws": [{"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "38"}, {"groupId": "FG001", "numSubjects": "51"}, {"groupId": "FG002", "numSubjects": "42"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "20"}, {"groupId": "FG001", "numSubjects": "19"}, {"groupId": "FG002", "numSubjects": "16"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Control Group", "description": "PM programming according to actual clinical practice\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "BG001", "title": "MVP Only", "description": "PM programming according to actual clinical practice + MVP algorithm ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "BG002", "title": "DDDRP", "description": "PM programming according to actual clinical practice + MVP algorithm ON + Atrial fibrillation therapies ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "BG003", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "385"}, {"groupId": "BG001", "value": "398"}, {"groupId": "BG002", "value": "383"}, {"groupId": "BG003", "value": "1166"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "73", "spread": "9"}, {"groupId": "BG001", "value": "74", "spread": "9"}, {"groupId": "BG002", "value": "74", "spread": "9"}, {"groupId": "BG003", "value": "74", "spread": "9"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "180"}, {"groupId": "BG001", "value": "188"}, {"groupId": "BG002", "value": "210"}, {"groupId": "BG003", "value": "578"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "205"}, {"groupId": "BG001", "value": "210"}, {"groupId": "BG002", "value": "173"}, {"groupId": "BG003", "value": "588"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Italy", "categories": [{"measurements": [{"groupId": "BG000", "value": "203"}, {"groupId": "BG001", "value": "211"}, {"groupId": "BG002", "value": "202"}, {"groupId": "BG003", "value": "616"}]}]}, {"title": "Netherlands", "categories": [{"measurements": [{"groupId": "BG000", "value": "41"}, {"groupId": "BG001", "value": "43"}, {"groupId": "BG002", "value": "39"}, {"groupId": "BG003", "value": "123"}]}]}, {"title": "Spain", "categories": [{"measurements": [{"groupId": "BG000", "value": "16"}, {"groupId": "BG001", "value": "18"}, {"groupId": "BG002", "value": "17"}, {"groupId": "BG003", "value": "51"}]}]}, {"title": "Portugal", "categories": [{"measurements": [{"groupId": "BG000", "value": "43"}, {"groupId": "BG001", "value": "44"}, {"groupId": "BG002", "value": "44"}, {"groupId": "BG003", "value": "131"}]}]}, {"title": "Austria", "categories": [{"measurements": [{"groupId": "BG000", "value": "15"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "15"}, {"groupId": "BG003", "value": "44"}]}]}, {"title": "France", "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}, {"groupId": "BG003", "value": "2"}]}]}, {"title": "Germany", "categories": [{"measurements": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "3"}, {"groupId": "BG003", "value": "16"}]}]}, {"title": "Greece", "categories": [{"measurements": [{"groupId": "BG000", "value": "23"}, {"groupId": "BG001", "value": "25"}, {"groupId": "BG002", "value": "25"}, {"groupId": "BG003", "value": "73"}]}]}, {"title": "Hong Kong", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "1"}, {"groupId": "BG003", "value": "3"}]}]}, {"title": "Israel", "categories": [{"measurements": [{"groupId": "BG000", "value": "7"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "8"}, {"groupId": "BG003", "value": "22"}]}]}, {"title": "Kuwait", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "3"}, {"groupId": "BG003", "value": "9"}]}]}, {"title": "Russian Federation", "categories": [{"measurements": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "11"}, {"groupId": "BG002", "value": "9"}, {"groupId": "BG003", "value": "30"}]}]}, {"title": "Slovakia", "categories": [{"measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "6"}, {"groupId": "BG003", "value": "16"}]}]}, {"title": "Switzerland", "categories": [{"measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "7"}, {"groupId": "BG003", "value": "23"}]}]}, {"title": "Taiwan", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "3"}, {"groupId": "BG003", "value": "7"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "SECONDARY", "title": "Death for All Causes at 2 Years", "description": "Incidence, estimated via Kaplan Meier survival analysis, of death for any cause at 2 years", "populationDescription": "The analysis was intention to treat therefore all randomized patients were included in the analysis", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of participants", "timeFrame": "2 years", "groups": [{"id": "OG000", "title": "Control Group", "description": "PM programming according to actual clinical practice\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "OG001", "title": "MVP Only", "description": "PM programming according to actual clinical practice + MVP algorithm ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "OG002", "title": "DDDRP", "description": "PM programming according to actual clinical practice + MVP algorithm ON + Atrial fibrillation therapies ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "383"}, {"groupId": "OG001", "value": "398"}, {"groupId": "OG002", "value": "383"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.6", "lowerLimit": "3.6", "upperLimit": "8.5"}, {"groupId": "OG001", "value": "5.1", "lowerLimit": "3.3", "upperLimit": "7.9"}, {"groupId": "OG002", "value": "4.6", "lowerLimit": "2.8", "upperLimit": "7.3"}]}]}]}, {"type": "SECONDARY", "title": "Incidence of Permanent Atrial Fibrillation at 2 Years", "description": "Incidence, estimated via Kaplan Meier survival analysis, of permanent atrial fibrillation at 2 years", "populationDescription": "The analysis was intention to treat therefore all randomized patients were analysed", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of participants", "timeFrame": "2 years", "groups": [{"id": "OG000", "title": "Control Group", "description": "PM programming according to actual clinical practice\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "OG001", "title": "MVP Only", "description": "PM programming according to actual clinical practice + MVP algorithm ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "OG002", "title": "DDDRP", "description": "PM programming according to actual clinical practice + MVP algorithm ON + Atrial fibrillation therapies ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "383"}, {"groupId": "OG001", "value": "398"}, {"groupId": "OG002", "value": "385"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "9.2", "lowerLimit": "6.6", "upperLimit": "12.7"}, {"groupId": "OG001", "value": "7.7", "lowerLimit": "5.3", "upperLimit": "11.0"}, {"groupId": "OG002", "value": "3.8", "lowerLimit": "2.2", "upperLimit": "6.5"}]}]}]}, {"type": "SECONDARY", "title": "Incidence of Cardiovascular Hospitalizations at 2 Years", "description": "Incidence, estimated via Kaplan Meier survival analysis, of cardiovascular hospitalizations at 2 years", "populationDescription": "Analysis was intention to treat therefore all randomized patients were analysed", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of participants", "timeFrame": "2 years", "groups": [{"id": "OG000", "title": "Control Group", "description": "PM programming according to actual clinical practice\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "OG001", "title": "MVP Only", "description": "PM programming according to actual clinical practice + MVP algorithm ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "OG002", "title": "DDDRP", "description": "PM programming according to actual clinical practice + MVP algorithm ON + Atrial fibrillation therapies ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "383"}, {"groupId": "OG001", "value": "398"}, {"groupId": "OG002", "value": "385"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "16.8", "lowerLimit": "13.3", "upperLimit": "21.2"}, {"groupId": "OG001", "value": "13.7", "lowerLimit": "10.5", "upperLimit": "17.7"}, {"groupId": "OG002", "value": "15.2", "lowerLimit": "11.8", "upperLimit": "19.4"}]}]}]}, {"type": "SECONDARY", "title": "Burden of Composite Clinical Endpoint", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Subjects' Symptoms", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Heart Failure Medications", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Cumulative Percentage of Ventricular Pacing", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Cardiovascular Death", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Any Hospitalization", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Atrial Fibrillation Burden", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Persistent Atrial Fibrillation (AF)", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Adverse Events", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Development of Atrioventricular (AV) Block and Pacemaker Dependency", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Predictors of Stroke, Transient Ischemic Attack (TIA) and Arterial Embolism", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Echocardiogram Data About Left Ventricular Fractional Shortening and Ejection Fraction and Left Atrium Dilatation", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Clinical Outcome in All the Patients With MVP ON Between Patients With Optimized AV-delay and Patients Without Optimized AV-delay", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Time to Development of the Composite Endpoint Between All Randomized Subjects in the Three Arms in Subgroups of Patients", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "SECONDARY", "title": "Frequency, Type, and Associated Cost of Health Care Utilization and Utility", "reportingStatus": "NOT_POSTED", "timeFrame": "2 years"}, {"type": "PRIMARY", "title": "Composite Endpoint Composed by Death for Any Cause, Cardiovascular Hospitalization or Permanent AF at 2 Years", "description": "The outcome measurement is the 2 years incidence, calculated by Kaplan Meier survival analysis, of the composite endpoint composed by death for any cause, cardiovascular hospitalization or permanent AF.", "populationDescription": "Analysis was intention to treat therefore all randomized patients were considered in the analyses", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of participants", "timeFrame": "2 years", "groups": [{"id": "OG000", "title": "Control Group", "description": "PM programming according to actual clinical practice\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "OG001", "title": "MVP Only", "description": "PM programming according to actual clinical practice + MVP algorithm ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}, {"id": "OG002", "title": "DDDRP", "description": "PM programming according to actual clinical practice + MVP algorithm ON + Atrial fibrillation therapies ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "385"}, {"groupId": "OG001", "value": "398"}, {"groupId": "OG002", "value": "383"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "28.0", "lowerLimit": "23.7", "upperLimit": "32.9"}, {"groupId": "OG001", "value": "23.1", "lowerLimit": "19.1", "upperLimit": "27.8"}, {"groupId": "OG002", "value": "21.5", "lowerLimit": "17.6", "upperLimit": "26.2"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "eventGroups": [{"id": "EG000", "title": "Control Group", "description": "PM programming according to actual clinical practice\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming", "seriousNumAffected": 180, "seriousNumAtRisk": 385, "otherNumAffected": 0, "otherNumAtRisk": 385}, {"id": "EG001", "title": "MVP Only", "description": "PM programming according to actual clinical practice + MVP algorithm ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming", "seriousNumAffected": 165, "seriousNumAtRisk": 398, "otherNumAffected": 0, "otherNumAtRisk": 398}, {"id": "EG002", "title": "DDDRP", "description": "PM programming according to actual clinical practice + MVP algorithm ON + Atrial fibrillation therapies ON\n\nPacemaker Medtronic EnRhythm: Pacemaker specific programming", "seriousNumAffected": 169, "seriousNumAtRisk": 383, "otherNumAffected": 0, "otherNumAtRisk": 383}], "seriousEvents": [{"term": "Anemia", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 383}]}, {"term": "Coagulation problem", "organSystem": "Blood and lymphatic system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 383}]}, {"term": "Acute Cornary Syndrome/Acute Myocardial Infarction", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 7, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 6, "numAffected": 5, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 5, "numAffected": 5, "numAtRisk": 383}]}, {"term": "Atrial Arrhythmia", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 58, "numAffected": 42, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 71, "numAffected": 50, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 42, "numAffected": 38, "numAtRisk": 383}]}, {"term": "AV conduction disorders", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 383}]}, {"term": "Cardiac death", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 8, "numAffected": 8, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 8, "numAffected": 8, "numAtRisk": 383}]}, {"term": "General cardiovascular disorders", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 383}]}, {"term": "Heart Failure", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 17, "numAffected": 13, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 16, "numAffected": 13, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 16, "numAffected": 13, "numAtRisk": 383}]}, {"term": "Sudden Cardiac Arrest", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 383}]}, {"term": "Sympthoms of chest pain, angina, palpitation, dyspnea on exertion or cardiopalmo", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 16, "numAffected": 13, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 9, "numAffected": 7, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 8, "numAffected": 8, "numAtRisk": 383}]}, {"term": "Ventricular Tachycardia or Fibrillation", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 6, "numAffected": 6, "numAtRisk": 383}]}, {"term": "Glucose metabolism disorders", "organSystem": "Endocrine disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 383}]}, {"term": "Hyperthyroidism", "organSystem": "Endocrine disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 383}]}, {"term": "Eye disease", "organSystem": "Eye disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 383}]}, {"term": "Gastrointestinal disorders", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 16, "numAffected": 10, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 6, "numAffected": 5, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 8, "numAffected": 7, "numAtRisk": 383}]}, {"term": "Death for non cardiac reason", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 10, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 15, "numAffected": 15, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 8, "numAffected": 8, "numAtRisk": 383}]}, {"term": "Death for unknown causes", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 15, "numAffected": 15, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 13, "numAffected": 13, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 25, "numAffected": 25, "numAtRisk": 383}]}, {"term": "Hemorrage", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 7, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 7, "numAffected": 6, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 5, "numAffected": 5, "numAtRisk": 383}]}, {"term": "Hypertension", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 383}]}, {"term": "Other general disorders", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 24, "numAffected": 20, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 14, "numAffected": 14, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 16, "numAffected": 14, "numAtRisk": 383}]}, {"term": "Syncope", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 8, "numAffected": 8, "numAtRisk": 383}]}, {"term": "Gallbladdert disorder", "organSystem": "Hepatobiliary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 3, "numAffected": 1, "numAtRisk": 383}]}, {"term": "Hepatic disorder", "organSystem": "Hepatobiliary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 383}]}, {"term": "Infection and infestations", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 3, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 5, "numAffected": 4, "numAtRisk": 383}]}, {"term": "Consequences of drugs administration", "organSystem": "Injury, poisoning and procedural complications", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 383}]}, {"term": "Lead dislodgement", "organSystem": "Injury, poisoning and procedural complications", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 19, "numAffected": 17, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 19, "numAffected": 18, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 15, "numAffected": 15, "numAtRisk": 383}]}, {"term": "Pacemaker/Lead related complications", "organSystem": "Injury, poisoning and procedural complications", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 4, "numAffected": 4, "numAtRisk": 383}]}, {"term": "Ureteral catheter dysfunction or dislodgement", "organSystem": "Injury, poisoning and procedural complications", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 10, "numAffected": 1, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 383}]}, {"term": "Enteroscopy, colonoscopy or video capsule endoscopy procedure", "organSystem": "Investigations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 383}]}, {"term": "Muscoloskeletal disease", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 33, "numAffected": 23, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 11, "numAffected": 10, "numAtRisk": 383}]}, {"term": "Neoplasia", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 11, "numAffected": 8, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 7, "numAffected": 7, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 4, "numAffected": 4, "numAtRisk": 383}]}, {"term": "Prostate disorder", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 383}]}, {"term": "Renal or urinary disease", "organSystem": "Renal and urinary disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 9, "numAffected": 7, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 4, "numAffected": 3, "numAtRisk": 383}]}, {"term": "Acute Pulmonary Edema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 383}]}, {"term": "Bronchitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 3, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 383}]}, {"term": "Cronic Obstructive Pulmonary Disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 4, "numAffected": 2, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 2, "numAffected": 1, "numAtRisk": 383}]}, {"term": "Other respiratory, thoracic and mediastinal disorders", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 8, "numAffected": 8, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 8, "numAffected": 8, "numAtRisk": 383}]}, {"term": "Pneumonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 5, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 10, "numAffected": 7, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 383}]}, {"term": "Symptoms of dyspnea, shortness of breath, fatigue, cough and or tachypnea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 7, "numAffected": 4, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 4, "numAffected": 4, "numAtRisk": 383}]}, {"term": "Ablation", "organSystem": "Surgical and medical procedures", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 383}]}, {"term": "Coronary Artery Bypass Graft", "organSystem": "Surgical and medical procedures", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 383}]}, {"term": "Other cardiac surgical interventions", "organSystem": "Surgical and medical procedures", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 4, "numAffected": 4, "numAtRisk": 383}]}, {"term": "Other surgical interventions", "organSystem": "Surgical and medical procedures", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 11, "numAffected": 9, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 22, "numAffected": 21, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 16, "numAffected": 16, "numAtRisk": 383}]}, {"term": "Pacemaker replacement, explant or repositioning", "organSystem": "Surgical and medical procedures", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 17, "numAffected": 17, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 7, "numAffected": 7, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 17, "numAffected": 17, "numAtRisk": 383}]}, {"term": "Stent implantation/Angiography", "organSystem": "Surgical and medical procedures", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 5, "numAffected": 5, "numAtRisk": 383}]}, {"term": "Aneurysm", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 383}]}, {"term": "Coronary Artery Disease", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 383}]}, {"term": "Other cerebrovascular disorders", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 383}]}, {"term": "Other vascular disorders", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 383}]}, {"term": "Peripheral vascular disease", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 383}]}, {"term": "Stroke", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 383}]}, {"term": "Transient Ischemic Attack", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 385}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 398}, {"groupId": "EG002", "numEvents": 5, "numAffected": 4, "numAtRisk": 383}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Senior Clinical Research Manager", "organization": "Medtronic", "email": "andrea.grammatico@medtronic.com", "phone": "0039-0632814225"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}, {"id": "D000001281", "term": "Atrial Fibrillation"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000001145", "term": "Arrhythmias, Cardiac"}, {"id": "D000010335", "term": "Pathologic Processes"}], "browseLeaves": [{"id": "M4586", "name": "Atrial Fibrillation", "asFound": "Atrial Fibrillation", "relevance": "HIGH"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M4453", "name": "Arrhythmias, Cardiac", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}